247
Views
5
CrossRef citations to date
0
Altmetric
Review

Circulating tumor cells as prognostic biomarkers in breast cancer: current status and future prospects

, , , &
Pages 1037-1048 | Received 22 Apr 2021, Accepted 28 Jul 2021, Published online: 09 Aug 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (4)

Vasileios Vardas, Anastasios Tolios, Athina Christopoulou, Vassilis Georgoulias, Anastasia Xagara, Filippos Koinis, Athanasios Kotsakis & Galatea Kallergi. (2023) Immune Checkpoint and EMT-Related Molecules in Circulating Tumor Cells (CTCs) from Triple Negative Breast Cancer Patients and Their Clinical Impact. Cancers 15:7, pages 1974.
Crossref
Yong Peng, Jianhua Cui, Kaiwen Ma & Xi Zhong. (2023) Hsa_circ_0005273 acts as a sponge of miR ‐509‐3p to promote the malignant behaviors of breast cancer by regulating HMMR expression . Thoracic Cancer 14:9, pages 794-804.
Crossref
Oliver Hoffmann, Sebastian Wormland, Ann-Kathrin Bittner, Monika Collenburg, Peter A. Horn, Rainer Kimmig, Sabine Kasimir-Bauer & Vera Rebmann. (2022) Programmed death receptor ligand-2 (PD-L2) bearing extracellular vesicles as a new biomarker to identify early triple-negative breast cancer patients at high risk for relapse. Journal of Cancer Research and Clinical Oncology 149:3, pages 1159-1174.
Crossref
Thodoris Sklias, Vasileios Vardas, Evangelia Pantazaka, Athina Christopoulou, Vassilis Georgoulias, Athanasios Kotsakis, Yiannis Vasilopoulos & Galatea Kallergi. (2022) PARP-1 Expression and BRCA1 Mutations in Breast Cancer Patients’ CTCs. Cancers 14:7, pages 1731.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.